Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Cellamare

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
The American Journal of Cardiology|May 8, 2025
Corrigendum to Impella Versus Non-Impella for Nonemergent High-Risk Percutaneous Coronary Intervention The American Journal of Cardiology (2024) Volume 225, 15 August. Pages 4-9. DOI: 10.1016/j.amjcard.2024.05.038Pavan Reddy, Ilan Merdler, Cheng Zhang, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|January 25, 2025
Functional coronary microvascular dysfunction among patients with chronic kidney diseaseKalyan R Chitturi, Sant Kumar, Flavia Tejada Frisancho, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|February 2, 2025
Examining the relationship between monocytes and monocyte-derived ratios in post-percutaneous coronary intervention patients and their impact on coronary artery disease progressionIlan Merdler, Kalyan R Chitturi, Abhishek Chaturvedi, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|May 23, 2024
Is there additional value in adding Impella to veno-arterial extracorporeal membrane oxygenation in patients with cardiogenic shock?Ilan Merdler, Brian C Case, Mohit Pahuja, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|May 24, 2024
Exploring the interplay between coronary microvascular dysfunction and mental healthIlan Merdler, Kalyan R Chitturi, Abhishek Chaturvedi, et al.
The American Journal of Cardiology|July 5, 2025
Regional Disparities and Predictors of Intracoronary Imaging Use During Percutaneous Coronary Intervention in the United StatesAbhishek Chaturvedi, Matteo Cellamare, Beni R Verma, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|May 24, 2024
Coronary microvascular dysfunction and inflammation: Insights from the Coronary Microvascular Disease RegistryIlan Merdler, Kalyan R Chitturi, Abhishek Chaturvedi, et al.
The American Journal of Cardiology|September 4, 2023
Understanding the Reasons for Disparities in Screening of Minorities in Cardiovascular Clinical Trials: Insights from a Large Clinical Research CenterIlan Merdler, Brian C Case, Erin C Collins, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 7, 2025
Correlates of Hemodynamic Instability During Non-Emergent Percutaneous Coronary Intervention: Refining High-Risk Criteria for Utilizing Mechanical Circulatory SupportPavan Reddy, Waiel Abusnina, Felipe Quinones, et al.
The American Journal of Cardiology|December 23, 2022
The Evolving Impact of Myocardial Injury in Patients With COVID-19 Amid the Omicron Wave of the PandemicBrian C Case, Corey Shea, Hank Rappaport, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
The American Journal of Cardiology|May 8, 2025
Corrigendum to Impella Versus Non-Impella for Nonemergent High-Risk Percutaneous Coronary Intervention The American Journal of Cardiology (2024) Volume 225, 15 August. Pages 4-9. DOI: 10.1016/j.amjcard.2024.05.038Pavan Reddy, Ilan Merdler, Cheng Zhang, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|January 25, 2025
Functional coronary microvascular dysfunction among patients with chronic kidney diseaseKalyan R Chitturi, Sant Kumar, Flavia Tejada Frisancho, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|February 2, 2025
Examining the relationship between monocytes and monocyte-derived ratios in post-percutaneous coronary intervention patients and their impact on coronary artery disease progressionIlan Merdler, Kalyan R Chitturi, Abhishek Chaturvedi, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|May 23, 2024
Is there additional value in adding Impella to veno-arterial extracorporeal membrane oxygenation in patients with cardiogenic shock?Ilan Merdler, Brian C Case, Mohit Pahuja, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|May 24, 2024
Exploring the interplay between coronary microvascular dysfunction and mental healthIlan Merdler, Kalyan R Chitturi, Abhishek Chaturvedi, et al.
The American Journal of Cardiology|July 5, 2025
Regional Disparities and Predictors of Intracoronary Imaging Use During Percutaneous Coronary Intervention in the United StatesAbhishek Chaturvedi, Matteo Cellamare, Beni R Verma, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|May 24, 2024
Coronary microvascular dysfunction and inflammation: Insights from the Coronary Microvascular Disease RegistryIlan Merdler, Kalyan R Chitturi, Abhishek Chaturvedi, et al.
The American Journal of Cardiology|September 4, 2023
Understanding the Reasons for Disparities in Screening of Minorities in Cardiovascular Clinical Trials: Insights from a Large Clinical Research CenterIlan Merdler, Brian C Case, Erin C Collins, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 7, 2025
Correlates of Hemodynamic Instability During Non-Emergent Percutaneous Coronary Intervention: Refining High-Risk Criteria for Utilizing Mechanical Circulatory SupportPavan Reddy, Waiel Abusnina, Felipe Quinones, et al.
The American Journal of Cardiology|December 23, 2022
The Evolving Impact of Myocardial Injury in Patients With COVID-19 Amid the Omicron Wave of the PandemicBrian C Case, Corey Shea, Hank Rappaport, et al.
Pageof 6